Peroxisome proliferator-activated receptor α controls cellular cholesterol trafficking in macrophages

被引:58
|
作者
Chinetti-Gbaguidi, G
Rigamonti, E
Helin, L
Mutka, AL
Lepore, M
Fruchart, JC
Clavey, V
Ikonen, E
Lestavel, S
Staels, B [1 ]
机构
[1] Inst Pasteur, INSERM, UR 545, F-59019 Lille, France
[2] Univ Lille 2, Lille, France
[3] Univ Helsinki, Inst Biotechnol, Helsinki, Finland
关键词
nuclear receptors; gene regulation; atherosclerosis; cholesterol homeostasis;
D O I
10.1194/jlr.M500326-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mobilization of cholesterol from intracellular pools to the plasma membrane is a determinant that governs its availability for efflux to extracellular acceptors. NPC1 and NPC2 are proteins localized in the late endosome and control cholesterol transport from the lysosome to the plasma membrane. Here, we report that NPC1 and NPC2 gene expression is induced by oxidized LDL ( OxLDL) in human macrophages. Because OxLDLs contain natural activators of peroxisome proliferator-activated receptor alpha (PPAR alpha),a fatty acid-activated nuclear receptor, the regulation of NPC1 and NPC2 by PPAR alpha and the consequences on cholesterol trafficking were further studied. NPC1 and NPC2 expression is induced by synthetic PPAR alpha ligands in human macrophages. Furthermore, PPAR alpha activation leads to an enrichment of cholesterol in the plasma membrane. By contrast, incubation with progesterone, which blocks postlysosomal cholesterol trafficking, as well as NPC1 and NPC2 mRNA depletion using small interfering RNA, abolished ABCA1-dependent cholesterol efflux induced by PPAR alpha activators. These observations identify a novel regulatory role for PPAR alpha in the control of cholesterol availability for efflux that, associated with its ability to inhibit cholesterol esterification and to stimulate ABCA1 and scavenger receptor class B type I expression, may contribute to the stimulation of reverse cholesterol transport.
引用
收藏
页码:2717 / 2725
页数:9
相关论文
共 50 条
  • [41] Peroxisome proliferator-activated receptor β/δ goes vascular
    Bishop-Bailey, David
    CIRCULATION RESEARCH, 2008, 102 (02) : 146 - 147
  • [42] Peroxisome proliferator-activated receptor gamma in osteoarthritis
    Fahmi, Hassan
    Martel-Pelletier, Johanne
    Pelletier, Jean-Pierre
    Kapoor, Mohit
    MODERN RHEUMATOLOGY, 2011, 21 (01) : 1 - 9
  • [43] Role of peroxisome proliferator-activated receptor α in atherosclerosis
    Cao, Heng
    Wen, Gao
    Li, Hongli
    MOLECULAR MEDICINE REPORTS, 2014, 9 (05) : 1755 - 1760
  • [44] Peroxisome proliferator-activated receptor ligands in atherosclerosis
    Viles-Gonzalez, JF
    Choi, BG
    Fuster, V
    Badimon, JJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (11) : 1393 - 1403
  • [45] LOCALIZATION OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR IN THE BRAIN
    KAINU, T
    WIKSTROM, AC
    GUSTAFSSON, JA
    PELTOHUIKKO, M
    NEUROREPORT, 1994, 5 (18) : 2481 - 2485
  • [46] The pleiotropic functions of peroxisome proliferator-activated receptor γ
    Marie-Bernard Debril
    Jean-Paul Renaud
    Lluis Fajas
    Johan Auwerx
    Journal of Molecular Medicine, 2001, 79 : 30 - 47
  • [47] Peroxisome proliferator-activated receptor α target genes
    S. Mandard
    M. Müller
    S. Kersten
    Cellular and Molecular Life Sciences CMLS, 2004, 61 : 393 - 416
  • [48] Peroxisome proliferator-activated receptor γ:: the more the merrier?
    Argmann, CA
    Cock, TA
    Auwerx, J
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (02) : 82 - 92
  • [49] Stabilization of peroxisome proliferator-activated receptor α by the ligand
    Hirotani, M
    Tsukamoto, T
    Bourdeaux, J
    Sadano, H
    Osumi, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 288 (01) : 106 - 110
  • [50] Ligand selectivity of the peroxisome proliferator-activated receptor α
    Lin, QO
    Ruuska, SE
    Shaw, NS
    Dong, D
    Noy, N
    BIOCHEMISTRY, 1999, 38 (01) : 185 - 190